News & Updates

Individuals with refractory chronic cough (RCC) may find relief in BLU-5937, a selective P2X3 antagonist under development which showed favourable efficacy in reducing cough frequency in the phase IIb SOOTHE trial.

A territory-wide cohort study of Hong Kong cancer patients finds a low incidence of adverse events of specific interest (AESI) following vaccination with two doses of either BNT162b2 or CZ02.

The first-in-class attachment inhibitor fostemsavir, when combined with optimized background therapy (OBT), provides an important treatment option for heavily treated HIV-1 patients with multidrug resistance and limited available antiretroviral (ARV) options, a matching adjusted indirect comparison (MAIC) analysis has shown.

Infection of cerebrospinal fluid (CSF) shunts is usually caused by staphylococci, but antibiotic-resistant Gram-negative bacilli are also common and cannot be easily distinguished from other shunt infections, reveals a recent study.

In paediatric patients undergoing appendectomy, an insufficient antibiotic regimen may result in longer length of stay (LOS) and more infectious complications, which validates the expansion of a simple antibiotic regimen in cases of severe intra-abdominal findings, a study has shown. In uncomplicated cases of appendicitis, treatment with ampicillin-sulbactam (AS) is suggested.